Risk Model-Based Lung Cancer Screening : A Cost-Effectiveness Analysis.

导出 OA

翻译打印收藏纠错

第一作者： Iakovos,Toumazis

第一单位： Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas (I.T., M.H.).

作者： Iakovos,Toumazis ^[1] ; Pianpian,Cao ^[2] ; Koen,de Nijs ^[3] ; Mehrad,Bastani ^[4] ; Vidit,Munshi ^[5] ; Mehdi,Hemmati ^[1] ; Kevin,Ten Haaf ^[3] ; Jihyoun,Jeon ^[2] ; Martin,Tammemägi ^[6] ; G Scott,Gazelle ^[5] ; Eric J,Feuer ^[7] ; Chung Yin,Kong ^[8] ; Rafael,Meza ^[9] ; Harry J,de Koning ^[3] ; Sylvia K,Plevritis ^[10] ; Summer S,Han ^[11]

作者单位： Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas (I.T., M.H.). ^[1] Department of Epidemiology, University of Michigan, Ann Arbor, Michigan (P.C., J.J.). ^[2] Erasmus MC-University Medical Center, Rotterdam, the Netherlands (K. de N., K. ten H., H.J. de K.). ^[3] Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York (M.B.). ^[4] Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts (V.M., G.S.G.). ^[5] Department of Health Sciences, Brock University, St. Catharines, Ontario, Canada (M.T.). ^[6] Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland (E.J.F.). ^[7] Division of General Internal Medicine, Department of Medicine, Mount Sinai Hospital, New York, New York (C.Y.K.). ^[8] Department of Epidemiology, University of Michigan, Ann Arbor, Michigan, and Department of Integrative Oncology, BC Cancer Research Institute, British Columbia, Canada (R.M.). ^[9] Department of Biomedical Data Sciences, Stanford University, Stanford, California (S.K.P.). ^[10] Quantitative Sciences Unit, Department of Medicine, Stanford University, Stanford, California (S.S.H.). ^[11]